Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison

BACKGROUND: Cytokine storm is a marker of severity and severe mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia. Immunomodulatory treatments may reduce morbidity and mortality. OBJECTIVES: To determine whether a 7-day course of methylprednisolone (MP) administered with and wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Dujana Mostafa, Belhoul, Khawla Mohammad, Al Maazmi, Naama Abdelrahman, Ghayoor, Farah, Moin, Muneeba, Al Suwaidi, Mahra, Narainen, Meeruna, Makki, Maryam, AbdulRahman, Mahera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191304/
https://www.ncbi.nlm.nih.gov/pubmed/34153729
http://dx.doi.org/10.1016/j.jiph.2021.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191304/
https://www.ncbi.nlm.nih.gov/pubmed/34153729
http://dx.doi.org/10.1016/j.jiph.2021.06.003

Ejemplares similares